Breast cancers can be divided into five molecular subtypes which are two ER positive types (luminal A and luminal B) and three ER negative types (HER-2 expressing, basal-like, and normal breast-like) and have distinct clinical features, with markedly differing prognosis and clinical outcomes [8]. This evidence concerns the gene ESR1 and breast carcinoma.